These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3778510)

  • 1. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
    Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
    Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
    Burke PJ; Kalet BT; Koch TH
    J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the microsomal tamoxifen binding site.
    Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
    Mehta RR; DasGupta TK
    Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC; Clark JH
    Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen inhibition of prolactin action in the mouse mammary gland.
    Biswas R; Vonderhaar BK
    Endocrinology; 1991 Jan; 128(1):532-8. PubMed ID: 1846110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
    Gray JM; Ziemian L
    Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
    Lyman SD; Jordan VC
    Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tamoxifen in the chicken.
    Lazier CB
    J Steroid Biochem; 1987; 27(4-6):877-82. PubMed ID: 3320566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and antiestrogen binding sites in desmoid tumors.
    Lim CL; Walker MJ; Mehta RR; Das Gupta TK
    Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an antiestrogen-binding protein in high salt extracts of human breast cancer tissue.
    Kon OL
    J Steroid Biochem; 1985 Feb; 22(2):177-86. PubMed ID: 3982029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
    Lopes MC; Tavares MC; Vale MG; Carvalho AP
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogen binding within different pituitary cell populations. Comparison with androgen and estrogen receptors.
    Thieulant ML; Adelaide J; Duval J
    J Steroid Biochem; 1986 Jan; 24(1):395-9. PubMed ID: 3702423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
    Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
    Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.